EWTX – edgewise therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference [Yahoo! Finance]
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Edgewise Therapeutics (EWTX) was upgraded by HC Wainwright to "strong-buy".
Form 10-K Edgewise Therapeutics, For: Dec 31
Form 8-K Edgewise Therapeutics, For: Feb 26
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: Paradigm Biocapital Advisors LP
Form 4 Edgewise Therapeutics, For: Jan 21 Filed by: Edris Badreddin
Form 144 Edgewise Therapeutics, Filed by: Edris Badreddin
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.